NOVARTIS | WINSOME DIAMONDS | NOVARTIS/ WINSOME DIAMONDS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 26.4 | -0.0 | - | View Chart |
P/BV | x | 3.2 | - | - | View Chart |
Dividend Yield | % | 4.7 | 0.0 | - |
NOVARTIS WINSOME DIAMONDS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
NOVARTIS Mar-23 |
WINSOME DIAMONDS Mar-17 |
NOVARTIS/ WINSOME DIAMONDS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 763 | 1 | 97,852.6% | |
Low | Rs | 554 | NA | 184,666.7% | |
Sales per share (Unadj.) | Rs | 153.4 | 0 | - | |
Earnings per share (Unadj.) | Rs | 41.9 | -78.4 | -53.4% | |
Cash flow per share (Unadj.) | Rs | 44.3 | -78.0 | -56.8% | |
Dividends per share (Unadj.) | Rs | 47.50 | 0 | - | |
Avg Dividend yield | % | 7.2 | 0 | - | |
Book value per share (Unadj.) | Rs | 314.2 | -53.1 | -591.4% | |
Shares outstanding (eoy) | m | 24.69 | 106.61 | 23.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 0 | - | |
Avg P/E ratio | x | 15.7 | 0 | -228,484.5% | |
P/CF ratio (eoy) | x | 14.9 | 0 | -214,705.3% | |
Price / Book Value ratio | x | 2.1 | 0 | -20,625.3% | |
Dividend payout | % | 113.5 | 0 | - | |
Avg Mkt Cap | Rs m | 16,262 | 58 | 28,248.5% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 356 | 3 | 13,398.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 3,787 | 0 | - | |
Other income | Rs m | 581 | 639 | 90.9% | |
Total revenues | Rs m | 4,369 | 639 | 683.2% | |
Gross profit | Rs m | 651 | -1,775 | -36.7% | |
Depreciation | Rs m | 61 | 44 | 139.1% | |
Interest | Rs m | 18 | 7,177 | 0.2% | |
Profit before tax | Rs m | 1,154 | -8,356 | -13.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 120 | 4 | 2,953.3% | |
Profit after tax | Rs m | 1,034 | -8,360 | -12.4% | |
Gross profit margin | % | 17.2 | 0 | - | |
Effective tax rate | % | 10.4 | 0 | -21,386.4% | |
Net profit margin | % | 27.3 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 7,861 | 507 | 1,551.1% | |
Current liabilities | Rs m | 2,683 | 63,052 | 4.3% | |
Net working cap to sales | % | 136.7 | 0 | - | |
Current ratio | x | 2.9 | 0 | 36,458.5% | |
Inventory Days | Days | 1,201 | 0 | - | |
Debtors Days | Days | 35 | 0 | - | |
Net fixed assets | Rs m | 12,656 | 56,934 | 22.2% | |
Share capital | Rs m | 123 | 1,065 | 11.6% | |
"Free" reserves | Rs m | 7,634 | -6,728 | -113.5% | |
Net worth | Rs m | 7,757 | -5,664 | -137.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,517 | 57,441 | 35.7% | |
Interest coverage | x | 66.9 | -0.2 | -40,755.6% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.2 | 0 | - | |
Return on assets | % | 5.1 | -2.1 | -248.8% | |
Return on equity | % | 13.3 | 147.6 | 9.0% | |
Return on capital | % | 15.1 | 20.8 | 72.6% | |
Exports to sales | % | 2.1 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 80 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 80 | 0 | - | |
Fx outflow | Rs m | 946 | 0 | - | |
Net fx | Rs m | -866 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 448 | 7,171 | 6.2% | |
From Investments | Rs m | -1,533 | 1 | -126,652.9% | |
From Financial Activity | Rs m | -305 | -7,177 | 4.2% | |
Net Cashflow | Rs m | -1,389 | -5 | 26,065.7% |
Indian Promoters | % | 0.0 | 25.2 | - | |
Foreign collaborators | % | 70.7 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.7 | 2.4 | 30.1% | |
FIIs | % | 0.2 | 2.3 | 8.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 29.3 | 74.8 | 39.2% | |
Shareholders | 41,239 | 47,477 | 86.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare NOVARTIS With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA MSTC
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Novartis | SU-RAJ DIAMONDS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.18% | 0.00% | -0.57% |
1-Month | -2.51% | -2.78% | 0.07% |
1-Year | 75.33% | -30.00% | 52.18% |
3-Year CAGR | 16.45% | -14.50% | 14.04% |
5-Year CAGR | 8.26% | -57.60% | 19.13% |
* Compound Annual Growth Rate
Here are more details on the Novartis share price and the SU-RAJ DIAMONDS share price.
Moving on to shareholding structures...
The promoters of Novartis hold a 70.7% stake in the company. In case of SU-RAJ DIAMONDS the stake stands at 25.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Novartis and the shareholding pattern of SU-RAJ DIAMONDS.
Finally, a word on dividends...
In the most recent financial year, Novartis paid a dividend of Rs 47.5 per share. This amounted to a Dividend Payout ratio of 113.5%.
SU-RAJ DIAMONDS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Novartis, and the dividend history of SU-RAJ DIAMONDS.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.